A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Related Research units
Abstract
The aim of this paper is to apply the proposed consensus remission criteria to an acutely ill inpatient sample at admission and evaluate their adaptability in this patient population and pharmaceutical trials.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 7 |
| ISSN | 0176-3679 |
| Publication status | Published - 2010 |
| pubmed | 20927697 |
|---|
